Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Corbus Pharmaceuticals Holdings, Inc. on May 26, 2016. The filing details the voting results for the election of directors and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document serves solely to disclose the results of shareholder votes.
Guidance, Outlook, and Management Commentary
There is no guidance, outlook, or management commentary regarding future financial performance or risks in this filing. The only significant event reported is the successful ratification of EisnerAmper LLP as the independent auditor for the fiscal year ending December 31, 2016.
Important Facts for Investors to Verify
- Director Election: All five nominees (Dr. Yuval Cohen, Alan Holmer, David P. Hochman, Dr. Renu Gupta, and Avery W. Catlin) were elected with over 16.7 million votes "For" each.
- Auditor Ratification: The appointment of EisnerAmper LLP was approved with 24,527,128 votes "For" versus 9,061 "Against".
- Broker Non-Votes: Approximately 8.66 million shares were recorded as broker non-votes for the director election, indicating these shares were not voted on that specific matter.